Response to Risperidone Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder: Three Cases
J Clin Psychiatry 1996;57:594-595
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Sir: We read with great interest the three cases reported by McDougle et al., in which patients with OCD refractory to fluvoxamine were treated with risperidone. We have also had a positive experience combining risperidone with an SSRI in a patient with compulsive tattooing (case report pending review). We assume the authors were not able to acknowledge the small open add-on trial of risperidone reported by Jacobsen due to the lag time between submission and publication.